Company news
Therma Bright Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Therma Bright's International Patent Application for TherOZap(TM) Enters National Phases in the US, Europe & Canada
September 5, 2019
TherOZap(TM) Technology Test Results Prove Successful at Inhibiting Zika Virus During In-Vitro Tests
September 4, 2019
Therma Bright Inc. Continues Testing of TherOZap(TM) Technology Against the Zika Virus
July 3, 2019
Therma Bright Inc. in Final Stages of Testing TherOZap(TM) Technology Against the Zika Virus
March 28, 2019
Therma Bright Inc. Issues Update on Pain Relief Device and TherOZap(TM) Technology
December 18, 2018
Icon Exploration Inc. Executes Formal Share Exchange Agreement in Furtherance of its Change of Business Transaction
November 7, 2018
Therma Bright Inc. to Establish Subsidiary for Cannabis Related Devices
November 1, 2018
Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology Against the Zika Virus
October 11, 2018
Therma Bright Provides Corporate Update on Pain Relief Device Incorporating Medicinal Cannabis, Further Testing of TherOZap(TM) Technology Against the Zika Virus and Finalizes Multi-Use Activators
October 1, 2018
Therma Bright Adds Strategic Advisor, Too Jae Min, Professor, Department of Anesthesiology and Pain Medicine, Korea University
September 17, 2018
Therma Bright Announces 2nd Tranche Closing of Private Placement
July 11, 2018
Therma Bright Inc. Appoints New CFO
July 6, 2018
Therma Bright Inc. Adds Board Member, Provides Update and Option Grant
June 19, 2018
Therma Bright Extends Closings of Financings
June 11, 2018
Therma Bright Extends Closings of Financings and Completes Purchase of Domain Name "coldsores.com"
May 10, 2018
Therma Bright to Test Thermal Therapy Technology with CBD and THC for Pain Relief and Adds Dr. Steven Bennett and Bruno Maruzzo as Strategic Advisors
May 8, 2018
Therma Bright Announces 1st Tranche Financing for $550,000 Through an Equity Private Placement and Convertible Debenture Offering
April 27, 2018
Therma Bright Announces: Further Testing of TherOZap(TM) Technology at Inhibiting Zika and Other Mosquito Borne Diseases, Proposed Financings and Acquisition Update
April 19, 2018
Therma Bright to Amend Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device
April 3, 2018
Therma Bright Signs Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device
March 14, 2018
Therma Bright Finalizes Terms on Acquisition, Adds Advisory Board Member and Grants Options
March 2, 2018
Therma Bright Announces Completion of Debt Settlements
February 16, 2018
Jenex Announces Continuation to BC and Name Change to "Therma Bright Inc."
February 7, 2018
Jenex Announces Non-Binding Letter of Intent with Quinsam Capital Corp. for $250,000 Investment to Develop CBD and THC Related Thermal Therapy Technology for Pain Relief and Other Pain Related Applications
February 1, 2018
Jenex Completes Due Diligence on Acquisition Targets
January 30, 2018
The Jenex Corporation Announces Board Change; Appointment of Advisory Board, Debt Settlement and Option Grants
January 17, 2018
Jenex's TherOZap(TM) Technology Indicates Effectiveness in Inhibiting Zika Virus After Pre-Clinical Study
January 8, 2018
The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition
December 12, 2017
The Jenex Corporation Announces Completion of Debt Settlement, Files TherOZap(TM) Device Patent and Presents at Chinese Global Financial Forum
December 4, 2017
The Jenex Corporation Announces AGM Results and Submits Application to Graduate to TSXV
November 23, 2017
The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets
November 2, 2017
The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)
October 12, 2017
The Jenex Corporation Announces Grant of Stock Options
October 6, 2017
The Jenex Corporation Terminates Exclusive License Agreement with Luminar Media Group Inc.
October 2, 2017
The Jenex Corporation Announces Approvals of Equity Financing & Move to TSX Venture Exchange (TSXV)
September 19, 2017
Jenex Reports Expected Date of Test Results for TherOZap(TM) at Inactivating the Zika Virus
September 14, 2017
Jenex is Unaware of Any Material Change
August 30, 2017
The Jenex Corporation Announces Conditional Acceptance of Reactivation from NEX to TSX Venture Exchange, TherOZap(TM) Testing and ISO 13485: 2003 Update
August 17, 2017
The Jenex Corporation Completes $317,500 Oversubscribed Non-Brokered Private Placement with Insider Participation
June 21, 2017
The Jenex Corporation Announces Equity Financing with Insider Participation
May 29, 2017
Jenex Finalizing Protocol to Test TherOZap(TM) Against the Zika Virus with University Health Network
May 23, 2017
Jenex to Test TherOZap(TM) Working Prototype and Topical Cannabidiol Oil Against the Zika and West Nile Viruses
April 18, 2017
CORRECTION FROM SOURCE: Jenex Completes Design of TherOzap(TM) Working Prototype and Signs Service Agreement with University Health Network to Initiate Testing Against the Zika and West Nile Viruses
April 7, 2017
Jenex Completes Design of TherOZap(TM) Working Prototype and Signs Service Agreement with University Heath Network to initiate testing against the Zika and West Nile Viruses
April 7, 2017
The Jenex Corporation Announces Shares For Debt Closing
April 6, 2017
Jenex Provides Update on TherOZap(TM) Working Prototype, and InterceptCS
March 6, 2017
Jenex Unaware of Any Material Change
February 27, 2017
Jenex Announces Proposed Debt Settlement
February 13, 2017
Jenex Provides Update on Next Generation Technology, TherOZap(TM) to Test Against the West Nile Virus and Zika Virus
January 24, 2017
Jenex to Test Next Generation Technology, TherOZap(TM) Against the Zika Virus and West Nile Virus
December 8, 2016